Quantcast

Bioterrorism: Inexpensive, and built to stay that way

The threat of bioterrorism is growing as more countries try to develop biological weapons, a CIA analyst told members of the Secretary of Health and Human Services’ Council on Public Health Preparedness. “Biological warfare is an attractive option . . . because it’s relatively inexpensive to develop,” said Kimberly Stergulz, an analyst at the CIA’s Weapons, Intelligence, Nonproliferation and Arms Control Center. A result, she said, is that countries such as Iraq, Iran, North Korea, Libya and Syria, and a growing number of non-state groups, are pursuing the capability. As reported by the Atlanta Journal Constitution, the CIA employee told the council that developing a biological weapons program could cost about $10 million, compared with $100 million to develop chemical weapon capability or $2 billion for nuclear capability. Stergulz presented the information at the first meeting of the council, a group of 21 health specialists and scientists who will advise the federal government on different aspects of potential public health emergencies.




The material in this press release comes from the originating research organization. Content may be edited for style and length. Want more? Sign up for our daily email.